Blood Pressure Monitoring Devices Market (By Product: Digital Blood Pressure Monitor, Sphygmomanometer, Ambulatory Blood Pressure Monitor, Instruments and Accessories, and Transducers; By End-use: Ambulatory Surgical Centers & Clinics, Hospitals, and Home Healthcare) - Global Market Size, Trends Analysis, Segment Forecasts, Regional Outlook 2024 - 2033
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
7.1. Blood Pressure Monitoring Devices Market, by Product Type, 2024-2033
7.1.1. Digital Blood Pressure Monitor (Wrist, Arm, Finger)
7.1.1.1. Market Revenue and Forecast (2021-2033)
7.1.2. Sphygmomanometer
7.1.2.1. Market Revenue and Forecast (2021-2033)
7.1.3. Ambulatory Blood Pressure Monitor
7.1.3.1. Market Revenue and Forecast (2021-2033)
7.1.4. Instruments & Accessories
7.1.4.1. Market Revenue and Forecast (2021-2033)
7.1.5. Transducers
8.1. Blood Pressure Monitoring Devices Market, by End-Use, 2024-2033
8.1.1. Ambulatory Surgical Centers & Clinics
8.1.1.1. Market Revenue and Forecast (2021-2033)
8.1.2. Hospitals
8.1.2.1. Market Revenue and Forecast (2021-2033)
8.1.3. Home Healthcare
8.1.3.1. Market Revenue and Forecast (2021-2033)
9.1. North America
9.1.1. Market Revenue and Forecast, by Product (2021-2033)
9.1.2. Market Revenue and Forecast, by End-Use (2021-2033)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, by Product (2021-2033)
9.1.3.2. Market Revenue and Forecast, by End-Use (2021-2033)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, by Product (2021-2033)
9.1.4.2. Market Revenue and Forecast, by End-Use (2021-2033)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Product (2021-2033)
9.2.2. Market Revenue and Forecast, by End-Use (2021-2033)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, by Product (2021-2033)
9.2.3.2. Market Revenue and Forecast, by End-Use (2021-2033)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, by Product (2021-2033)
9.2.4.2. Market Revenue and Forecast, by End-Use (2021-2033)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, by Product (2021-2033)
9.2.5.2. Market Revenue and Forecast, by End-Use (2021-2033)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, by Product (2021-2033)
9.2.6.2. Market Revenue and Forecast, by End-Use (2021-2033)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Product (2021-2033)
9.3.2. Market Revenue and Forecast, by End-Use (2021-2033)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, by Product (2021-2033)
9.3.3.2. Market Revenue and Forecast, by End-Use (2021-2033)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, by Product (2021-2033)
9.3.4.2. Market Revenue and Forecast, by End-Use (2021-2033)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, by Product (2021-2033)
9.3.5.2. Market Revenue and Forecast, by End-Use (2021-2033)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, by Product (2021-2033)
9.3.6.2. Market Revenue and Forecast, by End-Use (2021-2033)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Product (2021-2033)
9.4.2. Market Revenue and Forecast, by End-Use (2021-2033)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, by Product (2021-2033)
9.4.3.2. Market Revenue and Forecast, by End-Use (2021-2033)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, by Product (2021-2033)
9.4.4.2. Market Revenue and Forecast, by End-Use (2021-2033)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, by Product (2021-2033)
9.4.5.2. Market Revenue and Forecast, by End-Use (2021-2033)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, by Product (2021-2033)
9.4.6.2. Market Revenue and Forecast, by End-Use (2021-2033)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Product (2021-2033)
9.5.2. Market Revenue and Forecast, by End-Use (2021-2033)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, by Product (2021-2033)
9.5.3.2. Market Revenue and Forecast, by End-Use (2021-2033)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, by Product (2021-2033)
9.5.4.2. Market Revenue and Forecast, by End-Use (2021-2033)
10.1. Koninklijke Philips N.V.
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. General Electric Company
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. A & D Company, Limited
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. SunTech Medical, Inc.
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Welch Allyn
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. American Diagnostic Corporation
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. Briggs Healthcare
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. Withings
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. Spacelabs Healthcare
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. GF HEALTH PRODUCTS, INC.
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
10.11. Kaz, A Helen of Troy Company
10.11.1. Company Overview
10.11.2. Product Offerings
10.11.3. Financial Performance
10.11.4. Recent Initiatives
10.12. Rossmax International Limited
10.12.1. Company Overview
10.12.2. Product Offerings
10.12.3. Financial Performance
10.12.4. Recent Initiatives
10.13. Microlife Corporation
10.13.1. Company Overview
10.13.2. Product Offerings
10.13.3. Financial Performance
10.13.4. Recent Initiatives
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
12.1. About Us
12.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample